Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind active-controlled trial of live attenuated varicella vaccine in healthy people aged 13 years and older
CTR20230968Phase 3Active
- Sponsor
- Shanghai Rongsheng Biotech Co., Ltd.
- Start
- May 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of varicella vaccine live in chickenpox, sponsored by Shanghai Rongsheng Biotech Co., Ltd.. Started May 2023; status: active.
02
Drugs
varicella vaccine live
03
Conditions
chickenpox
Beyond the preview
Go deeper on CTR20230968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230968.